D&D Pharma, LLC dba MedScript Compounding Pharmacy
FDA inspection history in Noblesville, Indiana, 2019
- 1
- Form 483
Every document, by year
- Form 483
2019: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2019One Form 483, at Noblesville, Indiana.
Cited most
Across all D&D Pharma, LLC dba MedScript Compounding Pharmacy observations on file
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.160General requirements1
- 21 CFR 211.192Production record review1
The complete D&D Pharma, LLC dba MedScript Compounding Pharmacy file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Noblesville, Indiana
One Form 483 · 2019 · 3 observations
Latest: Form 483, Jul 17, 2019 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2019-07-17 | 483 Form 483 | Noblesville, Indiana | 3 | $99 |
Investigators on these documents
Charles L. Zhou (1)Lewis K. Antwi (1)Michael Y. Philopoulos (1)
FEI number 3015147067 · most recent document Jul 17, 2019
About D&D Pharma, LLC dba MedScript Compounding Pharmacy
How many FDA Form 483s has D&D Pharma, LLC dba MedScript Compounding Pharmacy received?
FDA Intel has 1 Form 483 on file for D&D Pharma, LLC dba MedScript Compounding Pharmacy; the most recent is dated Jul 17, 2019.
When was D&D Pharma, LLC dba MedScript Compounding Pharmacy last inspected by FDA?
The most recent FDA inspection document on file for D&D Pharma, LLC dba MedScript Compounding Pharmacy is a Form 483 dated Jul 17, 2019, for the site in Noblesville, Indiana.
What did FDA cite at D&D Pharma, LLC dba MedScript Compounding Pharmacy?
The regulations cited most in the observations on file for D&D Pharma, LLC dba MedScript Compounding Pharmacy are 21 CFR 211.113 (Control of microbiological contamination), 1 time; 21 CFR 211.160 (General requirements), 1 time; 21 CFR 211.192 (Production record review), 1 time.